Guidance Documents

These supportive documents either describe in detail how a specific procedure is required to be performed or suggest direction on operational processes and workflows.

They have been developed by University offices with relevant knowledge and expertise. Some documents identify mandatory processes; however, all documents are being shared as resources.

*Please check with your group regarding supplemental guidelines established by your department.

Guidance Document Title	Description	Version Date
Clinical Trial Agreement (CTA) Guidance		April 2022
MTA/DTA Processes for Review and Signature Approval By University of Utah Human Research Protection Program (HRPP) Units		May 2024
Non-Industry Fee Schedule / Site Budget Guidance		November 2022

Guidance Document Title

Description

Version Date

Clinical Trial Agreement (CTA) Guidance

April 2022

MTA/DTA Processes for Review and Signature Approval By University of Utah Human Research Protection Program (HRPP) Units

May 2024

Non-Industry Fee Schedule / Site Budget Guidance

November 2022

Disclaimer: This content is part of the OQC Web Archive. It consists of documents created prior to Compliance Date (April 24, 2026) and is retained exclusively for reference, research, and recordkeeping purposes. This content has not been altered or updated since its archival date and may not conform to the WCAG 2.1 Level AA technical standards.

If you require this document in an accessible format, please submit your request, including the document title and link, to oris-webmaster@utah.edu. We will provide a conforming alternate version promptly.